Yuki Etani

Effects of prior osteoporosis treatment on 12-month treatment response of romosozumab in patients with postmenopausal osteoporosis

Kosuke Ebina, Hideki Tsuboi, Yoshio Nagayama et al. · Joint Bone Spine · 2021 · 65 citations

Bone Disease, 12-Month Treatment Response, Bone Health +5

Effects of prior osteoporosis treatment on early treatment response of romosozumab in patients with postmenopausal osteoporosis

Kosuke Ebina, Makoto Hirao, Hideki Tsuboi et al. · Bone · 2020 · 60 citations · Full text

Bone Disease, Bone Health, Osteopathy +6

Apolipoprotein E plays crucial roles in maintaining bone mass by promoting osteoblast differentiation via ERK1/2 pathway and by suppressing osteoclast differentiation via c-Fos, NFATc1, and NF-κB pathway

Takaaki Noguchi, Kosuke Ebina, Makoto Hirao et al. · Biochemical and Biophysical Research Communications · 2018 · 43 citations

Developmental Biology, Signal Transduction, Apolipoprotein E +11

Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study

Kosuke Ebina, Tôru Hirano, Yuichi Maeda et al. · Scientific Reports · 2022 · 37 citations · Full text

A novel anti-TNF-α drug ozoralizumab rapidly distributes to inflamed joint tissues in a mouse model of collagen induced arthritis

Shohei Oyama, Kosuke Ebina, Yuki Etani et al. · Scientific Reports · 2022 · 33 citations · Full text